Reply to "Cost-of-illness of myelodysplastic syndromes in Italy. A reply to Tse et al." [0.03%]
关于"Tse等关于骨髓增生异常综合征的研究"的答复("意大利骨髓增生异常综合征的疾病负担")
Preston Tse,Shitong Xie,Jiajun Yan et al.
Preston Tse et al.
Cost-effectiveness analysis of immune checkpoint inhibitors versus platinum-based doublet chemotherapy in the first-line treatment of advanced non-small-cell lung cancer with High PD-L1 expression in Japan [0.03%]
针对日本高PD-L1表达晚期非小细胞肺癌一线治疗的免疫检查点抑制剂与双联化疗药物成本效益分析
Chanon Nusawat,So Sato,Jumpei Taniguchi et al.
Chanon Nusawat et al.
Background: This study comprehensively evaluated the cost-effectiveness of pembrolizumab, atezolizumab, and nivolumab plus ipilimumab compared with platinum-based doublet chemotherapy as the first-line treatment for advan...
Cash-for-care and its impact on older adults' informal and formal long-term care use: evidence from continental European countries [0.03%]
长期护理支付与老年人的非正式和正式护理使用情况：欧洲大陆国家的证据
Viktoria Szenkurök
Viktoria Szenkurök
Complex intervention for MS patients in Germany - can it be cost-saving for the society? [0.03%]
德国多发性硬化症患者的复杂干预措施-能否节省社会成本？
Markus Krohn,Susan Raths,Steffen Fleßa
Markus Krohn
The cost-effectiveness of implantable loop recorder detection of atrial fibrillation to prevent stroke in persons at high risk: An economic evaluation alongside a multicentre randomised controlled trial in Denmark (The LOOP Study) [0.03%]
丹麦植入式事件记录仪检测高危人群心房颤动以预防卒中的成本效益分析——来自LOOP研究的多中心随机对照试验的经济学评价
Christian Kronborg,Line Planck Kongstad,Søren Zöga Diederichsen et al.
Christian Kronborg et al.
Mobile money and households' ability to respond to health shocks in Africa: Evidence from Madagascar [0.03%]
移动支付与非洲家庭应对健康冲击的能力——来自马达加斯加的证据
Gbêtondji Melaine Armel Nonvide
Gbêtondji Melaine Armel Nonvide
Promoting the use of mobile money seems to be an important way of improving financial inclusion and households ability to cope with health shocks. This study aims to analyze the impact of mobile money usage on households ability to respond ...
Cost-effectiveness analysis of influenza vaccination with high-dose vaccine versus standard-dose quadrivalent vaccine in older adults in Spain [0.03%]
西班牙老年人群体中高剂量与标准剂量四价流感疫苗的疗效及成本分析研究
Jose-Maria Abellan-Perpiñan,Esther Redondo Margüello,Ángel Gil de Miguel et al.
Jose-Maria Abellan-Perpiñan et al.
Introduction and objectives: Influenza is a widespread acute respiratory illness which represents a significant public health challenge from both the National Health Service (NHS) and societal perspective, especially in t...
Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in Germany [0.03%]
德国多中心真实世界研究中allo-HSCT后接受莱特莫韦预防CMV患者的医疗资源利用和成本分析
Marie Engelhard,Sebastian M Wingen-Heimann,Annika Y Classen et al.
Marie Engelhard et al.
Objectives: Letermovir has demonstrated efficacy and tolerability as prophylaxis against clinically significant cytomegalovirus infection (csCMVi) in CMV-seropositive adult patients undergoing allogeneic hematopoietic cel...